Caroline Quill, MD, associate professor of medicine at the University of Rochester Medical Center, discussed how artificial intelligence (AI) and digital technologies could revolutionize chronic obstructive pulmonary disease (COPD) diagnosis and treatment at the CHEST 2024 annual meeting in Boston, […]
AI, Digital Technologies Set to Revolutionize COPD Care, Expert Says Read More »
High pre- and postdiagnosis alternate Mediterranean diet (AMED) scores were associated with improved overall survival (OS) in patients with ovarian cancer (OC), according to a study published in the Journal of Translational Medicine.1 The researchers explained that OC is the
Next week, clinicians and investigators will head to Boston, Massachusetts, for the 90th annual CHEST Meeting to explore current chest medicine challenges and anticipate future developments in the field. The meeting appeals to experts from all areas of chest medicine,
CHEST Ships Up to Boston for 90th Annual Meeting Read More »
On this episode of Managed Care Cast, we’re talking with Rick Chapman, PhD, chief science officer of the Center for Innovation & Value Research, formerly known as the Innovation and Value Initiative (IVI). We discussed the Center’s Rare Disease project,
Dr Rick Chapman Discusses Key Insights From the Center’s Rare Disease Project Read More »
Opioid use, with or without benzodiazepine use, was associated with increased long-term all-cause mortality in patients with chronic obstructive pulmonary disease (COPD) aged older than 60 years, according to a study published today in the International Journal of Chronic Obstructive
Opioids, Benzodiazepines Linked to Higher Mortality in Older Patients With COPD Read More »
National Ovarian Cancer Awareness Month provided an opportunity to raise awareness about ovarian cancer risks, the importance of early screening, and the ongoing disparities in care. September marks Ovarian Cancer Awareness Month, highlighting the importance of early detection and the
Prioritizing Early Detection, Bridging Equity Gaps Read More »
The FDA approved dupilumab (Dupixent; Regeneron/Sanofi) today for treating patients with uncontrolled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype.1 This approval makes dupilumab the first biologic treatment for COPD. It is a human monoclonal antibody that inhibits the
FDA Approves Dupilumab as First Biologic Treatment for COPD Read More »
Linda Bosserman, MD, PhD, FASCO, FACP, medical oncologist and professor at City of Hope, highlights the importance of implementing cutting-edge cancer treatments, which was a focus of the panel discussion “Bringing Academic Medicine and Optimal Cancer Care to the Community”
Expanding Access to Innovative Cancer Treatments Read More »
Linda Bosserman, MD, PhD, FASCO, FACP, medical oncologist and professor at City of Hope, identifies key gaps in value-based cancer care, emphasizing the need to balance cost and care to improve patient outcomes and quality of life. She discussed this
Closing Gaps in Value-Based Cancer Care Read More »
Andrew Leitner, MD, pain management physician and chair of the department of supportive care medicine at City of Hope, lists the key barriers to incorporating supportive care into value-based oncology care. He also discusses ways to provide patients from underserved
Increasing Access to Supportive Oncology Care Can Drive Health Equity Read More »
